Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 76 results found. Search for [ Dr. Randeep Guleria ]

Results 1 to 21 of 76
BusinessToday.In
New Delhi, May 5, 2021
Despite seeing a slight drop in the COVID-19 cases, the COVID emergency in India remains worrying which has overwhelmed hospitals and caused a crisis of life-saving resources such as oxygen. After registering over 4 lakh COVID-19 cases on Saturday, the country has been seeing a dip in the daily COVID cases. All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said that India may see a third wave of the coronavirus pandemic if the virus continues to evolve further and develops an immune escape mechanism. He rejected the idea of night curfews and weekend lockdowns to bring down the COVID-19 cases. But, when will the COVID second wave touch its peak and how will it impact the country's COVID graph? Experts explain.Also Read: COVID wave III imminent; we need to prepare, warns top scientist


BusinessToday.In
May 5, 2021
RT-PCR tests need not be conducted if an individual has tested positive once through rapid antigen tests (RAT) as per latest ICMR guidelines


BusinessToday.In
New Delhi, May 4, 2021
All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said on Tuesday that India may see a third wave of the coronavirus pandemic if the virus continues to evolve further and develops an immune escape mechanism. Guleria rejected the night curfews and weekend lockdowns that some states have imposed to bring down the COVID-19 cases, saying a lockdown for a sufficient duration is needed to cut the virus transmission. Speaking with India Today TV, the AIIMS chief added that the variants India is seeing are more infectious than what was seen last year. Watch the video for more.Also Read: South India's N440K COVID variant 15 times more lethal


BusinessToday.In
May 4, 2021
Dr Guleria mentioned that people are going for a CT scan the moment they find out that they are COVID-19 positive, adding that misuse of CT scans and biomarkers may cause damage


PTI
April 12, 2021
Around February, when cases started to decrease, people became lax towards following COVID-appropriate behaviour as they thought the virus had become ineffective, says AIIMS Director Dr Randeep Guleria


BusinessToday.In
April 2, 2021
Dr Randeep Guleria said young people are more affected this time and the severity of symptoms among them is lesser. However, he warned that the young people could transmit the virus to the elderly, which will further swamp the health infrastructure


PTI
March 21, 2021
Maharashtra continues to report the highest daily new cases at 27,126. It is followed by Punjab with 2,578 while Kerala reported 2,078 new cases. Karnataka, Gujarat and Madhya Pradesh reported 1,798, 1,565 and 1, 308 infections in a day


BusinessToday.In
March 1, 2021
The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states


BusinessToday.In
February 27, 2021
Union Information and Broadcasting Minister Prakash Javadekar said those who go to government centres will be administered the vaccine free of cost


BusinessToday.In
January 19, 2021
According to experts, people have adopted a \"wait and watch\" approach which has resulted in low turnout at vaccination centres


BusinessToday.In
January 16, 2021
A total of 16,755 vaccinators participated in the vaccination process across India, the ministry added. Not a single case of hospitalisation post-vaccine administration has been reported yet


BusinessToday.In
January 16, 2021
In the first phase of the vaccination drive over 3 crores frontline healthcare workers are expected to be given the vaccine. They will receive either Covaxin or Covishield COVID-19 vaccines which were approved for emergency use earlier by the country's drug regulators


BusinessToday.In
New Delhi, January 16, 2021
After Prime Minister Narendra Modi rolled out the nationwide coronavirus immunisation programme, a sanitation worker at the All India Institute of Medical Sciences (AIIMS), New Delhi, became the first person to receive the COVID-19 vaccine shot on Saturday. The first shot was followed by vaccinating other doctors, nurses and healthcare workers, including All India Institute of Medical Sciences (AIIMS) chief Dr Randeep Guleria. Union health minister Harsh Vardhan was also present at the hospital, administering the launch of the vaccination drive. Watch the video for more.Also Read: PM Modi launches COVID-19 vaccination drive; urges Indians to take both shots, follow protocols


BusinessToday.In
January 16, 2021
In the consent form for getting Covaxin vaccine, recipients have been promised that in case of any adverse situation following the administration of the vaccine and if it is determined that the vaccine was the cause then the recipients will be given compensation and medical


BusinessToday.In
January 16, 2021
Coronavirus vaccination drive: It brings me great pride that Covishield is part of this historic effort, said Serum Institute CEO Adar Poonawalla


BusinessToday.In
January 16, 2021
PM Modi launches COVID-19 vaccination drive: Urging people to take the vaccine and to take the complete course PM Modi allayed fears surrounding the jab. He said that when it comes to vaccines, India enjoys scientific credibility


BusinessToday.In
January 16, 2021
COVID-19 vaccination drive India: Dr Guleria was the third person to take the shot. Before him, a sanitation worker and a healthcare worker got vaccinated


PTI
January 14, 2021
Around 3 lakh frontline healthcare workers will be inoculated at 2,934 sites across the country on the first day of January 16, according to Health Ministry


BusinessToday.In
New Delhi, January 7, 2021
Dr Randeep Guleria, Director, AIIMS, in an interview with India Today TV talks about the plan for vaccination in India. Healthcare and frontline workers, the aged and people with comorbidities would be given priority. Dr Guleria explains.Also Read: 10% COVID-19 vaccines will be wasted, says Centre; to cost Rs 1,320 crore more


BusinessToday.In
January 4, 2021
Defending Covaxin, the Bhart Biotech Chairman said that his company has tremendous experience in developing vaccines; more than 70 articles on data related to Covaxin have been published in various journals


PAGES 1 OF 4  1234